StatSure Diagnostic Systems (SSUR) Stock Price, News & Analysis

Company Overview

StatSure Diagnostic Systems, Inc. is a publicly traded company that develops and commercial point-of-care diagnostic instruments and assays designed to simplify and decentralize coagulation testing. Headquartered in Herndon, Virginia, StatSure focuses on delivering rapid, accurate testing solutions that can be used in clinics, physician’s offices and other near-patient settings. The company’s technologies are intended to support healthcare providers in managing anticoagulant therapy, enabling timely dosing adjustments and improved patient outcomes.

The company’s core product platform centers on a compact benchtop analyzer paired with single-use, room-temperature–stable sample discs. Clinicians collect a small fingerstick blood sample onto the disc, insert it into the analyzer and receive prothrombin time (PT) and international normalized ratio (INR) results within minutes. By integrating dried reagents directly into the sample matrix, StatSure’s system eliminates the need for cold-chain storage and reduces the complexity of test preparation, making it well suited for decentralized environments where traditional laboratory infrastructure may be limited.

StatSure’s diagnostics platform addresses a growing global demand for point-of-care coagulation monitoring, especially among patients receiving vitamin K antagonists or other anticoagulant therapies. While the company primarily serves the U.S. market, it has also sought partnerships and distribution channels in select international regions. StatSure continues to explore additional assays and enhancements to its analyzer platform, with the aim of broadening its product portfolio and extending its reach across diverse clinical settings.

Key Stats

• Today's Range: $0.0002 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.0002 to $0.0002
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SSUR Stock Analysis - Frequently Asked Questions

How have SSUR shares performed this year?

StatSure Diagnostic Systems' stock was trading at $0.0002 at the beginning of 2025. Since then, SSUR shares have increased by 0.0% and is now trading at $0.0002.

How do I buy shares of StatSure Diagnostic Systems?

Shares of SSUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/16/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:SSUR
• CIK: N/A
• Web: www.statsurediagnostics.com
• Phone: (917) 417-4489
• Fax: 718-228-2522
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -0.99